Seqirus Inc. logo

Seqirus Inc.

71 Marks
First Filed:May 19, 2021Latest Filed:Mar 2, 2026Address:475 Green Oaks Parkway, Holly Springs, NC 27540, US

Portfolio Overview

Pending
64(90%)
Dead
7(10%)

Top Classes

Class 5
Pharmaceuticals
61(86%)
Class 44
Medical, beauty and agricultural services
34(48%)
Class 42
Software, IT Services & Scientific Research
33(46%)

TTAB Proceedings

Total Proceedings
2
As Plaintiff
1(50%)
As Defendant
1(50%)

Top Firms

Fross Zelnick Lehrman & Ziss...(Aug 2025)
64
Sunstein LLP(Jul 2021)
1

Trademark Activity Timeline(2021 – 2026)

Trademark Portfolio

71 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY
Owner:
Serial:99677818
Filed:Mar 2, 2026
Classes:42, 44
FLUTEAM
FLUTEAM
Trademark
Word
PENDING
Owner:
Serial:99641490
Filed:Feb 9, 2026
Classes:5, 42, 44
Goods & Services
Class 005: Vaccines; vaccines for human use; flu vaccines; Class 042: Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Class 044: Medical information; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics
FLUPANION
FLUPANION
Trademark
Word
PENDING
Owner:
Serial:99636428
Filed:Feb 5, 2026
Classes:5, 42, 44
Goods & Services
Class 005: Vaccines; vaccines for human use; flu vaccines; Class 042: Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Class 044: Medical information; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics
AUJEMFLU
AUJEMFLU
Trademark
Combined
PENDING
Owner:
Serial:99597199
Filed:Jan 15, 2026
Classes:5
Goods & Services
Class 005: Vaccines
AUJEMFLU
AUJEMFLU
Trademark
Combined
PENDING
Owner:
Serial:99597190
Filed:Jan 15, 2026
Classes:5
Goods & Services
Class 005: Vaccines
SICKONREPEAT
SICKONREPEAT
Service Mark
Word
PENDING
Owner:
Serial:99596915
Filed:Jan 15, 2026
Classes:44
Goods & Services
Class 044: Providing educational information and medical information about immunology, Primary Immunodeficiency and Immunoglobulin G, as well as educational materials distributed in connection therewith
AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE
Owner:
Serial:99358160
Filed:Aug 26, 2025
Classes:5
Goods & Services
Class 005: Vaccines
AU
AU
Trademark
Combined
PENDING
Owner:
Serial:99356186
Filed:Aug 25, 2025
Classes:5
Goods & Services
Class 005: Vaccines
KOSTAIVE
KOSTAIVE
Trademark
Combined
PENDING
Owner:
Serial:98371941
Filed:Jan 23, 2024
Classes:5
Goods & Services
Vaccines
IMKOVRUS
IMKOVRUS
Trademark
Word
PENDING
Owner:
Serial:98214643
Filed:Oct 9, 2023
Classes:5
Goods & Services
Pharmaceutical preparations and substances for human use for the treatment and prevention of viral and respiratory diseases and disorders; vaccines
KEPVERSO
KEPVERSO
Trademark
Word
PENDING
Owner:
Serial:98214645
Filed:Oct 9, 2023
Classes:5
Goods & Services
Pharmaceutical preparations and substances for human use for the treatment and prevention of viral and respiratory diseases and disorders; vaccines
COVIBELQ
COVIBELQ
Trademark
Word
PENDING
Owner:
Serial:97916514
Filed:May 2, 2023
Classes:5
Goods & Services
Vaccines
COVSTAIVE
COVSTAIVE
Trademark
Word
PENDING
Owner:
Serial:97916545
Filed:May 2, 2023
Classes:5
Goods & Services
Vaccines
KOSTAIVE
KOSTAIVE
Trademark
Word
PENDING
Owner:
Serial:97916534
Filed:May 2, 2023
Classes:5
Goods & Services
Vaccines
QEMTIER
QEMTIER
Trademark
Word
PENDING
Owner:
Serial:97916541
Filed:May 2, 2023
Classes:5
Goods & Services
Vaccines
QULVASTAY
QULVASTAY
Trademark
Word
PENDING
Owner:
Serial:97916528
Filed:May 2, 2023
Classes:5
Goods & Services
Vaccines
FLUHIRO
FLUHIRO
Trademark
Word
PENDING
Owner:
Serial:97746309
Filed:Jan 9, 2023
Classes:5
Goods & Services
Vaccines
SAMURAI
SAMURAI
Trademark
Word
PENDING
Owner:
Serial:97746884
Filed:Jan 9, 2023
Classes:1, 5, 42, +1
Goods & Services
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing and treating viruses and respiratory disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, namely, messenger RNA and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells; Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research and medical research, namely, for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
FLOUDEFY
FLOUDEFY
Trademark
Word
PENDING
Owner:
Serial:97719659
Filed:Dec 15, 2022
Classes:5
Goods & Services
Vaccines
FLUCLIPSE
FLUCLIPSE
Trademark
Word
PENDING
Owner:
Serial:97719676
Filed:Dec 15, 2022
Classes:5
Goods & Services
Vaccines
FLUVANQUIS
FLUVANQUIS
Trademark
Word
PENDING
Owner:
Serial:97719634
Filed:Dec 15, 2022
Classes:5
Goods & Services
Vaccines
LEMNI
LEMNI
Trademark
Word
PENDING
Owner:
Serial:97668869
Filed:Nov 8, 2022
Classes:1, 5, 42, +1
Goods & Services
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells; Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
PEDIATRIC INFLUENZA LEADERSHIP FORUM
PENDING
Owner:
Serial:97668718
Filed:Nov 8, 2022
Classes:35, 41, 42, +1
Goods & Services
Educational services in the nature of seminars in the fields of leadership, medicine, pharmaceuticals, vaccines, and influenza and distribution of educational materials in connection therewith; leadership training programs in the fields of medicine, pharmaceuticals, vaccines, and influenza and distribution of educational materials in connection therewith; arranging and conducting conferences and meetings in the fields of leadership, medicine, pharmaceuticals, vaccines, and influenza; Promoting awareness of influenza immunization and vaccination programs; providing business consulting and consumer information services related to pharmaceuticals and vaccines; providing a website for practice management and administrative support services to healthcare providers, medical professionals, and pharmacies; providing online information for healthcare providers, medical professionals, and pharmacies about practice management and administrative support related to pharmaceuticals and vaccines; business management consultation in the field of leadership development; Medical services; health care services; medical information services; providing a website with medical information in the fields of influenza and the prophylactic and therapeutic properties of pharmaceuticals and vaccines; providing medical information in the fields of influenza and the prophylactic and therapeutic properties of pharmaceuticals and vaccines; pharmaceutical consultation; consulting services relating to the prophylactic and therapeutic properties of vaccines; "PEDIATRIC INFLUENZA LEADERSHIP FORUM"; Pharmaceutical research and development; medical research services; providing medical and scientific research in the fields of pharmaceuticals, vaccines, and influenza; providing information in the fields of pharmaceutical and vaccine research and development and influenza research; providing a website featuring information in the fields of pharmaceutical and vaccine research and influenza research; consulting services related to research and development of medicines, pharmaceuticals, and vaccines; technical consulting in the field of pharmaceutical studies
RALLION
RALLION
Trademark
Word
PENDING
Owner:
Serial:97668826
Filed:Nov 8, 2022
Classes:1, 5, 42, +1
Goods & Services
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells; Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
RAMPIR
RAMPIR
Trademark
Word
PENDING
Owner:
Serial:97668804
Filed:Nov 8, 2022
Classes:1, 5, 42, +1
Goods & Services
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells; Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
TRIUMPH
TRIUMPH
Trademark
Word
PENDING
Owner:
Serial:97668847
Filed:Nov 8, 2022
Classes:1, 5, 42, +1
Goods & Services
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells; Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
EXCELLFLU
EXCELLFLU
Trademark
Word
PENDING
Owner:
Serial:97600281
Filed:Sep 21, 2022
Classes:5
Goods & Services
Vaccines
EXCELFLU
EXCELFLU
Trademark
Word
PENDING
Owner:
Serial:97597194
Filed:Sep 19, 2022
Classes:5
Goods & Services
Vaccines
PLUZELFLU
PLUZELFLU
Trademark
Word
PENDING
Owner:
Serial:97524976
Filed:Jul 28, 2022
Classes:5
Goods & Services
Vaccines
SELKURTI
SELKURTI
Trademark
Word
PENDING
Owner:
Serial:97524966
Filed:Jul 28, 2022
Classes:5
Goods & Services
Vaccines
ZADJUZEL
ZADJUZEL
Trademark
Word
PENDING
Owner:
Serial:97524988
Filed:Jul 28, 2022
Classes:5
Goods & Services
Vaccines
ZELDJEVA
ZELDJEVA
Trademark
Word
PENDING
Owner:
Serial:97524979
Filed:Jul 28, 2022
Classes:5
Goods & Services
Vaccines
PHLUSELGA
PHLUSELGA
Trademark
Word
PENDING
Owner:
Serial:97519806
Filed:Jul 26, 2022
Classes:5
Goods & Services
Vaccines
KIGLAFLU
KIGLAFLU
Trademark
Word
PENDING
Owner:
Serial:97515576
Filed:Jul 22, 2022
Classes:5
Goods & Services
Vaccines
PHLUTEKRO
PHLUTEKRO
Trademark
Word
PENDING
Owner:
Serial:97514327
Filed:Jul 21, 2022
Classes:5
Goods & Services
Vaccines
APHLUA
APHLUA
Trademark
Word
PENDING
Owner:
Serial:97510192
Filed:Jul 19, 2022
Classes:5
Goods & Services
Vaccines
AUJEMFLU
AUJEMFLU
Trademark
Word
PENDING
Owner:
Serial:97510198
Filed:Jul 19, 2022
Classes:5
Goods & Services
Vaccines
EXZELFLU
EXZELFLU
Trademark
Word
PENDING
Owner:
Serial:97510168
Filed:Jul 19, 2022
Classes:5
Goods & Services
Vaccines
FLUTOLBY
FLUTOLBY
Trademark
Word
PENDING
Owner:
Serial:97510179
Filed:Jul 19, 2022
Classes:5
Goods & Services
Vaccines
PHLUDEPZY
PHLUDEPZY
Trademark
Word
PENDING
Owner:
Serial:97510210
Filed:Jul 19, 2022
Classes:5
Goods & Services
Vaccines
ZELADJEV
ZELADJEV
Trademark
Word
PENDING
Owner:
Serial:97510224
Filed:Jul 19, 2022
Classes:5
Goods & Services
Vaccines
DURVAXITY
DURVAXITY
Trademark
Word
PENDING
Owner:
Serial:97347180
Filed:Apr 5, 2022
Classes:1, 5, 42, +1
Goods & Services
Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
ECHOVAX
ECHOVAX
Trademark
Word
ABANDONED
Owner:
Serial:97347371
Filed:Apr 5, 2022
Classes:1
IMMUNECHO
IMMUNECHO
Trademark
Word
ABANDONED
Owner:
Serial:97347374
Filed:Apr 5, 2022
Classes:1
IMUEXPAND
IMUEXPAND
Trademark
Word
PENDING
Owner:
Serial:97347644
Filed:Apr 5, 2022
Classes:1, 5, 42, +1
Goods & Services
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells; Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
MRNATE
MRNATE
Trademark
Word
PENDING
Owner:
Serial:97347635
Filed:Apr 5, 2022
Classes:1, 5, 42, +1
Goods & Services
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells; Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
MULTIPLICITY
MULTIPLICITY
Trademark
Word
PENDING
Owner:
Serial:97347380
Filed:Apr 5, 2022
Classes:1, 5, 42, +1
Goods & Services
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells; Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
RNATE
RNATE
Trademark
Word
PENDING
Owner:
Serial:97347615
Filed:Apr 5, 2022
Classes:1, 5, 42, +1
Goods & Services
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells; Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
SEMPLETE
SEMPLETE
Trademark
Word
ABANDONED
Owner:
Serial:97347188
Filed:Apr 5, 2022
Classes:1
VAXECHO
VAXECHO
Trademark
Word
ABANDONED
Owner:
Serial:97347642
Filed:Apr 5, 2022
Classes:1
97263786
97263786
Trademark
Design
PENDING
Owner:
Serial:97263786
Filed:Feb 11, 2022
Classes:5, 42, 44
Goods & Services
Vaccines; vaccines for human use; flu vaccines; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information; Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development
ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGY
Owner:
Serial:97263776
Filed:Feb 11, 2022
Classes:42, 44
Goods & Services
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; and medical information; "STUDY CELL-BASED ADJUVANT TECHNOLOGY"; Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development
CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY
Owner:
Serial:97263760
Filed:Feb 11, 2022
Classes:42, 44
Goods & Services
Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics; "STUDY CELL-BASED ADJUVANT TECHNOLOGY"; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations; scientific research in the nature of conducting clinical trials for flu vaccines; providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development
THINK OUTSIDE THE SHELL
THINK OUTSIDE THE SHELL
Service Mark
Word
PENDING
Owner:
Serial:97239127
Filed:Jan 26, 2022
Classes:42, 44
Goods & Services
Providing a website featuring information in the field of medical services in the nature of administering vaccines; providing a website featuring medical and healthcare information; providing information about medical services in the nature of administering vaccines; providing medical and healthcare information; providing a website featuring medical information relating to the prophylactic and therapeutic properties of vaccines; providing medical information relating to the prophylactic and therapeutic properties of vaccines; Providing a website featuring information in the field of vaccine research and development; providing information about medical research in the field of vaccines
ADBOOST
ADBOOST
Trademark
Word
ABANDONED
Owner:
Serial:90894588
Filed:Aug 20, 2021
Classes:5
ALLY
ALLY
Trademark
Word
PENDING
Owner:
Serial:90894560
Filed:Aug 20, 2021
Classes:5, 42, 44
Goods & Services
vaccines; vaccines for human use; flu vaccines; Providing information relating to the prophylactic and therapeutic properties of flu vaccines; Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development in the field of flu vaccines; providing information about pharmaceutical research and development in the field of flu vaccines
ALLYFLU
ALLYFLU
Trademark
Word
PENDING
Owner:
Serial:90894552
Filed:Aug 20, 2021
Classes:5, 42, 44
Goods & Services
vaccines; vaccines for human use; flu vaccines; Medical information; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics; Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development
ALLYNZA
ALLYNZA
Trademark
Word
PENDING
Owner:
Serial:90894566
Filed:Aug 20, 2021
Classes:5, 42, 44
Goods & Services
vaccines; vaccines for human use; flu vaccines; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; and medical information, none of the foregoing for optician services, providing information relating to glasses, providing information relating to sunglasses, providing information relating to contact lenses, advisory and consultancy services and information relating to fitting of contact lenses, or vision correction and eye treatment; Scientific research in the nature of conducting clinical trials in the field of pharmaceutical preparations; conducting clinical trials in the field of flu vaccines; scientific research in the nature of providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development
CELLJUVANT
CELLJUVANT
Trademark
Word
PENDING
Owner:
Serial:90894570
Filed:Aug 20, 2021
Classes:5, 42, 44
Goods & Services
vaccines; vaccines for human use; flu vaccines; Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations; scientific research in the nature of conducting clinical trials for flu vaccines; providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development
CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY
Owner:
Serial:90894582
Filed:Aug 20, 2021
Classes:5, 42, 44
Goods & Services
vaccines; vaccines for human use; flu vaccines; Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics; "CELL-BASED ADJUVANT TECHNOLOGY"; Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development
FLUMATE
FLUMATE
Trademark
Word
ABANDONED
Owner:
Serial:90894608
Filed:Aug 20, 2021
Classes:5
FLUPANION
FLUPANION
Trademark
Word
PENDING
Owner:
Serial:90894454
Filed:Aug 20, 2021
Classes:5, 42, 44
Goods & Services
vaccines; vaccines for human use; flu vaccines; Medical information; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics; Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development
FLUTEAM
FLUTEAM
Trademark
Word
PENDING
Owner:
Serial:90894597
Filed:Aug 20, 2021
Classes:5, 42, 44
Goods & Services
vaccines; vaccines for human use; flu vaccines; Medical information; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics; Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development
MARISA
MARISA
Trademark
Word
PENDING
Owner:
Serial:90838099
Filed:Jul 20, 2021
Classes:1, 5, 42, +1
Goods & Services
Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
MAXINE
MAXINE
Trademark
Word
ABANDONED
Owner:
Serial:90838034
Filed:Jul 20, 2021
Classes:1, 5, 42, +1
Goods & Services
Vaccine adjuvants; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate the delivery of a wide range of pharmaceuticals; Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
MAZIE
MAZIE
Trademark
Word
PENDING
Owner:
Serial:90838056
Filed:Jul 20, 2021
Classes:1, 5, 42, +1
Goods & Services
Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
AMPLYRNA
AMPLYRNA
Trademark
Word
PENDING
Owner:
Serial:90758038
Filed:Jun 7, 2021
Classes:1, 5, 42, +1
Goods & Services
Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
RIBOPLUS
RIBOPLUS
Trademark
Word
PENDING
Owner:
Serial:90727723
Filed:May 21, 2021
Classes:1, 5, 42, +1
Goods & Services
Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
MIRIAM
MIRIAM
Trademark
Word
PENDING
Owner:
Serial:90720636
Filed:May 19, 2021
Classes:1, 5, 42, +1
Goods & Services
Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
MRNACT
MRNACT
Trademark
Word
PENDING
Owner:
Serial:90720622
Filed:May 19, 2021
Classes:1, 5, 42, +1
Goods & Services
Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
XCLEIC
XCLEIC
Trademark
Word
PENDING
Owner:
Serial:90720596
Filed:May 19, 2021
Classes:1, 5, 42, +1
Goods & Services
Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use; Medical services; medical information; providing a website featuring medical information; Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.